The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christ, M.
Right arrow Articles by Karlsson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christ, M.
Right arrow Articles by Karlsson, S.

The Journal of Immunology, Vol 153, Issue 5 1936-1946, Copyright © 1994 by American Association of Immunologists

ARTICLES

Immune dysregulation in TGF-beta 1-deficient mice

M Christ, NL McCartney-Francis, AB Kulkarni, JM Ward, DE Mizel, CL Mackall, RE Gress, KL Hines, H Tian and S Karlsson
Cellular Immunology Section, Laboratory of Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892.

Approximately 2 wk after birth, mice having a TGF-beta 1 null mutation (TGF-beta 1(-/-)) exhibit a progressive wasting syndrome and death. Associated with this phenotype is a multifocal infiltration of lymphocytes and macrophages into target organs, especially the heart, lungs, and salivary glands. To explore the consequences of TGF-beta 1 deficiency on the immune system, lymphocyte phenotype and function were analyzed. Initially, lymphoid organ architecture seemed to be normal and, as symptoms developed, the thymus decreased in size, whereas lymph nodes were enlarged. Phenotypically, the TGF-beta 1(-/-) lymphoid cells seemed to be more differentiated in the thymus and activated in the lymph nodes, but remarkably unaffected in the spleen. Moreover, TGF- beta 1(-/-) spleen and lymph nodes displayed enhanced numbers of proliferating cells, as measured by proliferating cell nuclear Ag and/or cyclin-dependent kinase levels. Consistent with this hyperproliferative response, constitutive levels of IL-2 mRNA were elevated in the thymus and both IL-2 and IL-2R mRNA were increased in the lymph nodes. In contrast with the activation profile of TGF-beta 1(- /-) lymphoid cells in vivo, mitogen challenge of these cells in vitro revealed suppressed proliferation that was associated with a defect in inducible IL-2 mRNA expression and IL-2 secretion. Moreover, the addition of rIL-2 restored the deficient mitogen-induced proliferation. The mechanism leading to T cell anergy remains unclear; however, these data confirm the essential role for TGF-beta 1 in maintaining normal immune function.


This article has been cited by other articles:


Home page
 BloodHome page
T. Hidaka, S. Nakahata, K. Hatakeyama, M. Hamasaki, K. Yamashita, T. Kohno, Y. Arai, T. Taki, K. Nishida, A. Okayama, et al.
Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma
Blood, July 15, 2008; 112(2): 383 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. S. Horan, S. Wood, V. Ona, D. J. Li, M. E. Lukashev, P. H. Weinreb, K. J. Simon, K. Hahm, N. E. Allaire, N. J. Rinaldi, et al.
Partial Inhibition of Integrin {alpha}v 6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 56 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Belmadani, J. Bernal, C.-C. Wei, M. A. Pallero, L. Dell'Italia, J. E. Murphy-Ullrich, and K. H. Berecek
A Thrombospondin-1 Antagonist of Transforming Growth Factor-{beta} Activation Blocks Cardiomyopathy in Rats with Diabetes and Elevated Angiotensin II
Am. J. Pathol., September 1, 2007; 171(3): 777 - 789.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Classen, T. Zander, D. Eggle, J. M. Chemnitz, B. Brors, I. Buchmann, A. Popov, M. Beyer, R. Eils, S. Debey, et al.
Human Resting CD4+ T Cells Are Constitutively Inhibited by TGFbeta under Steady-State Conditions
J. Immunol., June 1, 2007; 178(11): 6931 - 6940.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Y. Lan, Z. Wang, G. Raimondi, W. Wu, B. L. Colvin, A. De Creus, and A. W. Thomson
"Alternatively Activated" Dendritic Cells Preferentially Secrete IL-10, Expand Foxp3+CD4+ T Cells, and Induce Long-Term Organ Allograft Survival in Combination with CTLA4-Ig
J. Immunol., November 1, 2006; 177(9): 5868 - 5877.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Menoret, L. M. Myers, S.-J. Lee, R. S. Mittler, R. J. Rossi, and A. T. Vella
TGFbeta Protein Processing and Activity through TCR Triggering of Primary CD8+ T Regulatory Cells
J. Immunol., November 1, 2006; 177(9): 6091 - 6097.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Yoshino, H. Yamazaki, L. D. Shultz, and S.-I. Hayashi
Constant rate of steady-state self-antigen trafficking from skin to regional lymph nodes
Int. Immunol., November 1, 2006; 18(11): 1541 - 1548.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Oida, L. Xu, H. L. Weiner, A. Kitani, and W. Strober
TGF-beta-Mediated Suppression by CD4+CD25+ T Cells Is Facilitated by CTLA-4 Signaling
J. Immunol., August 15, 2006; 177(4): 2331 - 2339.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Dong and G. C. Blobe
Role of transforming growth factor-beta in hematologic malignancies
Blood, June 15, 2006; 107(12): 4589 - 4596.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Cohen, E. Mouly, H. Hamdi, M.-C. Maillot, M. Pallardy, V. Godot, F. Capel, A. Balian, S. Naveau, P. Galanaud, et al.
GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response
Blood, March 1, 2006; 107(5): 2037 - 2044.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. R. Pons, J. Sauleda, A. Noguera, J. Pons, B. Barcelo, A. Fuster, and A. G. N. Agusti
Decreased macrophage release of TGF-{beta} and TIMP-1 in chronic obstructive pulmonary disease
Eur. Respir. J., July 1, 2005; 26(1): 60 - 66.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. S. Jones, S. Akel, C. Petrow-Sadowski, Y. Huang, D. C. Bertolette, and F. W. Ruscetti
Induction of Human T Cell Leukemia Virus Type I Receptors on Quiescent Naive T Lymphocytes by TGF-{beta}
J. Immunol., April 1, 2005; 174(7): 4262 - 4270.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Naiki, K. S. Michelsen, W. Zhang, S. Chen, T. M. Doherty, and M. Arditi
Transforming Growth Factor-{beta} Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 Signaling
J. Biol. Chem., February 18, 2005; 280(7): 5491 - 5495.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. M. Wahl, J. Swisher, N. McCartney-Francis, and W. Chen
TGF-{beta}: the perpetrator of immune suppression by regulatory T cells and suicidal T cells
J. Leukoc. Biol., July 1, 2004; 76(1): 15 - 24.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Mamura, W. Lee, T. J. Sullivan, A. Felici, A. L. Sowers, J. P. Allison, and J. J. Letterio
CD28 disruption exacerbates inflammation in Tgf-{beta}1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-{beta}1
Blood, June 15, 2004; 103(12): 4594 - 4601.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Rosendahl, M. Speletas, K. Leandersson, F. Ivars, and P. Sideras
Transforming growth factor-{beta}- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis
Int. Immunol., December 1, 2003; 15(12): 1401 - 1414.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Larsson, U. Blank, H. Helgadottir, J. M. Bjornsson, M. Ehinger, M.-J. Goumans, X. Fan, P. Leveen, and S. Karlsson
TGF-{beta} signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro
Blood, November 1, 2003; 102(9): 3129 - 3135.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Kasprowicz, P. S. Smallwood, A. J. Tyznik, and S. F. Ziegler
Scurfin (FoxP3) Controls T-Dependent Immune Responses In Vivo Through Regulation of CD4+ T Cell Effector Function
J. Immunol., August 1, 2003; 171(3): 1216 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Z.-m. Chen, M. J. O'Shaughnessy, I. Gramaglia, A. Panoskaltsis-Mortari, W. J. Murphy, S. Narula, M. G. Roncarolo, and B. R. Blazar
IL-10 and TGF-{beta} induce alloreactive CD4+CD25- T cells to acquire regulatory cell function
Blood, June 15, 2003; 101(12): 5076 - 5083.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. H. Nelson, T. P. Martyak, L. J. Thompson, J. J. Moon, and T. Wang
Uncoupling of Promitogenic and Antiapoptotic Functions of IL-2 by Smad-Dependent TGF-{beta} Signaling
J. Immunol., June 1, 2003; 170(11): 5563 - 5570.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Bommireddy, V. Saxena, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, R. R. Singh, and T. Doetschman
TGF-{beta}1 Regulates Lymphocyte Homeostasis by Preventing Activation and Subsequent Apoptosis of Peripheral Lymphocytes
J. Immunol., May 1, 2003; 170(9): 4612 - 4622.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. L. McCartney-Francis and S. M. Wahl
Dysregulation of IFN-{gamma} Signaling Pathways in the Absence of TGF-{beta}1
J. Immunol., November 15, 2002; 169(10): 5941 - 5947.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. A. Piccirillo, J. J. Letterio, A. M. Thornton, R. S. McHugh, M. Mamura, H. Mizuhara, and E. M. Shevach
CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor {beta}1 Production and Responsiveness
J. Exp. Med., July 15, 2002; 196(2): 237 - 246.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Leveen, J. Larsson, M. Ehinger, C. M. Cilio, M. Sundler, L. J. Sjostrand, R. Holmdahl, and S. Karlsson
Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable
Blood, June 28, 2002; 100(2): 560 - 568.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Dennler, M.-J. Goumans, and P. ten Dijke
Transforming growth factor {beta} signal transduction
J. Leukoc. Biol., May 1, 2002; 71(5): 731 - 740.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Khattri, D. Kasprowicz, T. Cox, M. Mortrud, M. W. Appleby, M. E. Brunkow, S. F. Ziegler, and F. Ramsdell
The Amount of Scurfin Protein Determines Peripheral T Cell Number and Responsiveness
J. Immunol., December 1, 2001; 167(11): 6312 - 6320.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
W. Chen, W. Jin, H. Tian, P. Sicurello, M. Frank, J. M. Orenstein, and S. M. Wahl
Requirement for Transforming Growth Factor {beta}1 in Controlling T Cell Apoptosis
J. Exp. Med., August 20, 2001; 194(4): 439 - 454.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. D. Gorham, J. T. Lin, J. L. Sung, L. A. Rudner, and M. A. French
Genetic Regulation of Autoimmune Disease: BALB/c Background TGF-{{beta}}1-Deficient Mice Develop Necroinflammatory IFN-{{gamma}}-Dependent Hepatitis
J. Immunol., May 15, 2001; 166(10): 6413 - 6422.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld
Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis
Blood, September 15, 2000; 96(6): 2022 - 2036.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. J. Abraham, X. Shiwen, C. M. Black, S. Sa, Y. Xu, and A. Leask
Tumor Necrosis Factor alpha Suppresses the Induction of Connective Tissue Growth Factor by Transforming Growth Factor-beta in Normal and Scleroderma Fibroblasts
J. Biol. Chem., May 12, 2000; 275(20): 15220 - 15225.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Imai, A. Takeshita, and S. Hanazawa
Transforming Growth Factor-beta Inhibits Lipopolysaccharide-Stimulated Expression of Inflammatory Cytokines in Mouse Macrophages through Downregulation of Activation Protein 1 and CD14 Receptor Expression
Infect. Immun., May 1, 2000; 68(5): 2418 - 2423.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Kobayashi, K. Yoshida, J. M. Ward, J. J. Letterio, G. Longenecker, L. Yaswen, B. Mittleman, E. Mozes, A. B. Roberts, S. Karlsson, et al.
{beta}2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-{beta}1 Null Mouse
J. Immunol., October 1, 1999; 163(7): 4013 - 4019.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. W. v. Ginkel, S. M. Wahl, J. F. Kearney, M.-N. Kweon, K. Fujihashi, P. D. Burrows, H. Kiyono, and J. R. McGhee
Partial IgA-Deficiency with Increased Th2-Type Cytokines in TGF-{beta}1 Knockout Mice
J. Immunol., August 15, 1999; 163(4): 1951 - 1957.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. L. Brown, S. Patil, C. D. Cianci, J. S. Morrow, and P. H. Howe
Transforming Growth Factor beta Induces Caspase 3-independent Cleavage of alpha II-Spectrin (alpha -Fodrin) Coincident with Apoptosis
J. Biol. Chem., August 13, 1999; 274(33): 23256 - 23262.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. Haneda, K. Sano, G. Tamura, H. Shirota, Y. Ohkawara, T. Sato, S. Habu, and K. Shirato
Transforming Growth Factor-beta Secreted from CD4+ T Cells Ameliorates Antigen-Induced Eosinophilic Inflammation . A Novel High-Dose Tolerance in the Trachea
Am. J. Respir. Cell Mol. Biol., August 1, 1999; 21(2): 268 - 274.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
C. Mohan, Y. Yu, L. Morel, P. Yang, and E. K. Wakeland
Genetic Dissection of Sle Pathogenesis: Sle3 on Murine Chromosome 7 Impacts T Cell Activation, Differentiation, and Cell Death
J. Immunol., June 1, 1999; 162(11): 6492 - 6502.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. E. Harris-White, T. Chu, Z. Balverde, J. J. Sigel, K. C. Flanders, and S. A. Frautschy
Effects of Transforming Growth Factor-beta (Isoforms 1-3) on Amyloid-beta Deposition, Inflammation, and Cell Targeting in Organotypic Hippocampal Slice Cultures
J. Neurosci., December 15, 1998; 18(24): 10366 - 10374.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
W. Chen, W. Jin, and S. M. Wahl
Engagement of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor beta  (TGF-beta ) Production by Murine CD4+ T Cells
J. Exp. Med., November 16, 1998; 188(10): 1849 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. Koglin, T. Glysing-Jensen, A. Raisanen-Sokolowski, and M. E. Russell
Immune Sources of Transforming Growth Factor-ß1 Reduce Transplant Arteriosclerosis : Insight Derived From a Knockout Mouse Model
Circ. Res., September 21, 1998; 83(6): 652 - 660.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. S. Barone, D. D. Tolarova, I. Ormsby, T. Doetschman, and J. G. Michael
Induction of Oral Tolerance in TGF-{beta}1 Null Mice
J. Immunol., July 1, 1998; 161(1): 154 - 160.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Rakasz, A. M. Blum, A. Metwali, D. E. Elliott, J. Li, Z. K. Ballas, K. Qadir, R. Lynch, and J. V. Weinstock
Localization and Regulation of IFN-{gamma} Production Within the Granulomas of Murine Schistosomiasis in IL-4-Deficient and Control Mice
J. Immunol., May 15, 1998; 160(10): 4994 - 4999.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A. Creange, L. Belec, B. Clair, J.-D. Degos, J.-C. Raphael, and R. K Gherardi
Circulating transforming growth factor beta 1 (TGF-beta 1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function
J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 162 - 165.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
X. Chen, W. Liu, C. Ambrosino, M. R. Ruocco, V. Poli, L. Romani, I. Quinto, S. Barbieri, K. L. Holmes, S. Venuta, et al.
Impaired Generation of Bone Marrow B Lymphocytes in Mice Deficient in C/EBPbeta
Blood, July 1, 1997; 90(1): 156 - 164.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
F. Bridoux, A. Badou, A. Saoudi, I. Bernard, E. Druet, R. Pasquier, P. Druet, and L. Pelletier
Transforming Growth Factor beta  (TGF-beta )-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self-Major Histocompatibility Complex (MHC) Class II-specific, Regulatory CD4+ T Cell Lines
J. Exp. Med., May 19, 1997; 185(10): 1769 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
T. A. Borkowski, J. J. Letterio, A. G. Farr, and M. C. Udey
A Role for Endogenous Transforming Growth Factor beta 1 in Langerhans Cell Biology:  The Skin of   Transforming Growth Factor beta 1 Null Mice Is Devoid of  Epidermal Langerhans Cells
J. Exp. Med., December 15, 1996; 184(6): 2417 - 2422.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.